ClinicalTrials.Veeva

Menu

Retrospective Identification of Scintigraphic Cardiac Amyloidosis (RISCA)

U

University Hospital, Lille

Status

Not yet enrolling

Conditions

Transthyretin Amyloidosis
Cardiac Amyloidosis

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT06921408
2024_0111
ID RCB Number (Other Identifier)

Details and patient eligibility

About

This study aims to determine the positive predictive value of incidental cardiac uptake on bone scintigraphy for diagnosing transthyretin cardiac amyloidosis, in patients who underwent scintigraphy for reasons other than suspected amyloidosis. The study is an observational, descriptive, multicenter, national study using retrospective data from routine care. Patients with incidental cardiac uptake will be recalled for further diagnostic assessment.

Enrollment

57 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults (≥ 18 years)
  • Patients who underwent bone scintigraphy with 99mTc-HMDP/DPD/PYP for any indication
  • Incidental cardiac uptake (Perugini grade ≥2) confirmed by a nuclear medicine specialist

Exclusion criteria

  • Patients under legal protection
  • Patients refusing the reuse of their data after individual information

Trial contacts and locations

0

Loading...

Central trial contact

Marc-Antoine DELBARRE

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems